Key result
Pre-treatment with intracoronary low-dose urokinase before direct PTCA reduced the frequency of acute restenosis compared to PTCA alone in patients with acute myocardial infarction.
Why the study?
Does pre-treatment with intracoronary low-dose urokinase before direct PTCA reduce the frequency of acute restenosis in patients with acute myocardial infarction?
Cohort (n=272)
No
Does pre-treatment with intracoronary low-dose urokinase before direct PTCA reduce the frequency of acute restenosis in patients with acute myocardial infarction?
Pre-treatment with intracoronary low-dose urokinase before direct PTCA significantly reduces the frequency of acute restenosis in AMI patients with large coronary thrombi.
Answers are grounded in this paper and cite their sources.
May support urokinase pre-PTCA in select AMI; hypothesis-generating, requires RCTs before practice change.
To investigate the effect of pre-treatment of a thrombus with a low dose of urokinase on establishing patency in a persistent infarct-related artery (IRA) during direct percutaneous coronary angioplasty (PTCA), the frequency of acute restenosis during direct PTCA, alone, or in combination with the intracoronary administration of urokinase, was examined in a consecutive nonrandomized series of patients with acute myocardial infarction (AMI). Two hundred and seventy-two successful PTCA patients (residual stenosis <50%) were divided into 2 groups: 88 patients received pre-treatment with intracoronary urokinase following PTCA (combination group); 184 received only direct PTCA without thrombolytic therapy (PTCA group). In the present study, after achievement of a residual stenosis of less than 50%, IRA was visualized every 15 min to assess the frequency of acute restenosis, which was defined as an acute progression of IRA with more than 75% restenosis after initially successful PTCA. In the patients with a large coronary thrombus, the frequency (times) of acute restenosis was significantly lower in the combination group than in the PTCA group (0.98±0.19 vs 2.92±0.32, p<0.0001). On the other hand, in the patients with a small coronary thrombus, the frequency of acute restenosis showed no difference in either group. The present study indicates that in patients with AMI, PTCA combined with pre-treatment of a low dose of urokinase is much more effective than PTCA alone, especially for those patients who have a large coronary thrombus. (Jpn Circ J 1999; 63: 91 - 96)
No takes yet. Share an insight, caveat, or question.
Oshima et al. (1999) conducted a cohort in Acute Myocardial Infarction (n=272). Intracoronary urokinase vs. Direct PTCA alone was evaluated on Frequency of acute restenosis during the first 30 minutes after successful PTCA (p=<0.01). Pre-treatment with intracoronary low-dose urokinase before direct PTCA reduced the frequency of acute restenosis compared to PTCA alone in patients with acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: